According to a review article by the famous investment website Seekingalpha, signed by Cris Frangold, 3D printing technology has become one of the hottest new technologies. The development potential of 3D bio-printing technology is huge, and the future is expected. In a few years, it will achieve rapid growth and generate a lot of income.
This article refers to the address: http://
Organovo Holdings, a developer and manufacturer of 3D human tissue for medical research and medical devices, is working with cloud design and technology software vendor Autodesk to develop the first bioprint 3D design software.
The software will be used in conjunction with Organovo's NovoGen MMX bioprinter, demonstrating that humans are taking an important step forward in improving the usability and functionality of 3D human tissue design, potentially expanding the number of bioprinters. Organovo's 3D bioprinting technology creates 3D human tissue that structurally corrects and forms human cells. Organizations created in this way can function like native human tissue, which also provides opportunities for advanced drug discovery and development, and may be applied to clinical treatment and tissue transplantation in the future.
Autodesk is committed to developing state-of-the-art technologies such as human-computer interaction, computer graphics and digital design. It intends to extend its technology to software development for designing and simulating molecular and human systems.
What is 3D bioprinting?
Organovo is exploring new ways to print human tissue using materials that can produce body components and to use computerized adaptive manufacturing processes for human tissue transplantation. Custom samples and finished products are produced using inexpensive 3D computer printers. Instead of using extruded plastic, metal or ceramic materials, these medical printers use living cell materials. This process is called fast bioprinting. It is an innovative application of the standard technology used in traditional inkjet printers we are familiar with. These printers can create tissue structures of any shape, such as blood vessels, small skin and muscles.
Synergies between Organovo and Autodesk
The two companies have great potential for cooperation. Organovo's NovoGen MMX Bioprinter is a new, fully automated (customized graphical user interface) software and hardware platform developed to meet the diverse needs of biological research and bioprinting. From a hardware perspective, it's a powerful tool that uses the latest technology, but it runs on the latest software platforms. Every time scientists want to use a printer, they have to write the relevant software from scratch, which means that scientists spend a lot of time debugging software, not technical research.
Autodesk has become a leader in many professional design fields. All products that may have been developed over the past 20 years have been developed using Autodesk software, but this will be the first time it has been developed to create living things. software. The first application to be implemented in the next five years is likely to be a simple organization ready for clinical trials. At the same time, Organovo hopes to achieve a stable and sustainable source of income through the production of living tissue that can be used for drug research, discovery and development.
The development potential of 3D bio-printing technology
The best way to understand the potential of 3D bioprinting technology is to compare the evolution of other technologies that may have been completely unimaginable 20 years ago. Although the technology is different, it can still explain the problem. For example, the most typical example is the development of tablets and smartphones. Perhaps the main driver behind the development of tablet and smartphone technology is that consumers need a versatile, affordable, and practical portable device. Microsoft first introduced the commercial tablet Microsoft Tablet PC in 2002, but did not achieve the success Microsoft hoped. Eight years later, Apple launched the iPad in 2010, which broke the technical barrier. Today, tablets are already selling well in the global market, and it is expected to sell faster than laptops.
The development of 3D printing technology has become one of the hottest new technologies today. 3D printing technology dates back to 1984. This technology continues to move forward in accordance with Moore's Law, while costs are declining, gradually reducing to the extent that mainstream companies can use 3D printers. In the past two years, 3D Systems and Stratasys, market leaders in 3D printing, have been the two most popular companies. 3D printing companies have been developing rapidly in recent years. The 3D printer is expected to be the hottest topic at the CES show in Las Vegas in early January. 3D Systems' stock has risen 15% since the beginning of the year.
The 3D printing industry is expected to achieve rapid growth and generate large revenues in recent years as more and more companies are adopting this technology. Today, industry giants like Ford, Boeing and General Electric have begun to adopt 3D printing technology in their manufacturing processes.
According to Brian Mathews, vice president of Autodesk, "3D printing is a way to reimagine the manufacturing process." Ford used 3D printing technology to increase the speed and cost efficiency of sample manufacturing. Similarly, Boeing applies 3D printing technology to the manufacture of components for military aircraft. In November 2012, General Electric acquired Morris Technologies, an engineering technology company that invested heavily in 3D printing equipment, to focus on printing the various components of the latest jet engines.
It is not difficult to imagine that human tissue 3D printing technology is likely to continue to grow with similar growth trends.
According to Donate Life America, a US non-profit organization dedicated to increasing donations to human organs, eyes and tissues, “although medical technology and donations have been growing, the market’s demand for human organs, eyes and tissues is still far greater than donations. Quantity. In the United States alone, more than 115,000 people are waiting for organ transplants."
CompaniesandMarkets.com is a global business information aggregator with a number of expert analysts who have authored hundreds of market research reports.
According to an expert named Mike King, “The global artificial organ market is expected to reach US$20 billion by 2017, mainly due to the growing demand for patients requiring organ transplants. In addition, technological advances, cost reductions, an aging population and a small number of donated organs are also factors contributing to the surge in demand for artificial organs in the next few years."
The report also pointed out that due to more than 100 million people with diabetes worldwide, artificial pancreas is expected to have good prospects for development. The global demand for artificial organs is triggered by artificial kidneys.
in conclusion
Other companies are also actively researching and developing tissue regeneration and treatment technologies, such as Tengion, but they use traditional technology rather than bio-printing technology; those companies focus on different Organovo. 3D printing technology may take a long time to profit, although the investment risk in this technology area is high, but the potential return can be very large.
However, there are also short-term positive factors in this technology area, such as income from drug discovery and development. In 2010, Organovo signed a cooperation agreement with Pfizer, which is expected to receive $450,000 in revenue by the end of 2012. Later, it entered into a 30-month partnership with United Therapeutics in October 2011, and Organovo will use its bioprinting technology to conduct research related to pulmonary hypertension. Organovo has admitted that it has earned $618,000 in revenue from this partnership.
Usb-C To Usb-C Cables,Pd Fast Charging Usb Cable,Usb C To Type C Braided Cable,Usb Cable For Tablet
Dongguan Pinji Electronic Technology Limited , https://www.iqdatacable.com